Author: admin

Haemonetics (HAE) has seen a lift in its stock price over the past month, gaining more than 51%. This move stands out when compared to the company’s broader track record and recent financial performance.

See our latest analysis for Haemonetics.

This kind of sharp 30-day share price return, up more than 51%, signals a dramatic shift in sentiment for Haemonetics. This comes after a challenging year with a 12-month total shareholder return of -17.6%. Recent momentum may hint at renewed optimism about the company’s prospects as investors look past last year’s struggles and consider its potential for recovery.

If you’re interested in what else might be catching renewed investor attention, it’s a great moment to check out opportunities with other healthcare stocks using our See the full list for free.

With shares soaring more than 51% in just 30 days, the key question now is whether Haemonetics is truly undervalued or if this surge means future growth is already reflected in the market price.

Haemonetics’s most widely followed narrative places its fair value at $83, noticeably higher than the recent closing price of $73.49. This difference points to possible upside embedded in key growth and profitability assumptions that diverge from past market trends.

Rapid innovation and increased adoption of advanced plasma collection systems (NexSys with Persona and Express Plus), as well as new software contracts securing approximately 80% market share, are driving share gains and supporting double-digit organic growth ex-CSL in the plasma segment. These trends are expected to boost both revenue and net margins as upgrades and center conversions accelerate through FY26 and into FY27.

Read the complete narrative.

The key to this bullish view? It rests on a blueprint where profit margins climb, recurring revenues expand, and fresh innovation secures market dominance. Want to discover what bold projections lie behind this optimistic price target? The full narrative reveals the details shaping this valuation and the stakes if things do not go to plan.

Result: Fair Value of $83 (UNDERVALUED)

Have a read of the narrative in full and understand what’s behind the forecasts.

However, risks remain. Intensifying competition and dependence on a few core products could threaten Haemonetics’s growth if operational challenges persist.

Find out about the key risks to this Haemonetics narrative.

If you see the story differently or want to dig into the numbers yourself, it only takes a few minutes to build your own view. Do it your way

A great starting point for your Haemonetics research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.

Millions of investors are finding their edge by using targeted stock screeners. Let Simply Wall Street help you spot fresh opportunities before the crowd.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include HAE.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Nuvalent (NUVL) has scheduled a webcast to present pivotal data from its Phase 1/2 ALKOVE-1 study. The presentation will focus on an investigational ALK-selective inhibitor for advanced non-small cell lung cancer. This update is drawing attention from investors.

See our latest analysis for Nuvalent.

Nuvalent’s momentum has been hard to miss, with recent clinical updates and positive analyst coverage fueling a 26.9% share price return over the past 90 days. While the 1-year total shareholder return stands at just 11.1%, the three-year figure tells a much more impressive growth story at over 200%. This highlights how recent milestones are renewing confidence among investors seeking long-term potential.

If you’re curious about where biotech innovation is heading next, this could be the perfect time to explore See the full list for free.

Despite robust analyst enthusiasm and a share price still trading nearly 30% below the consensus price target, the question remains: is Nuvalent undervalued at its current levels, or is the market already accounting for its expected future gains?

Nuvalent is currently valued at a price-to-book ratio of 8.3x, which means investors are paying a premium relative to its net asset value. The last close was $96.50, and this ratio is a key gauge for high-growth, asset-light biotech firms.

The price-to-book ratio compares a company’s market price to the value of its assets on the balance sheet. For biotechs, where tangible assets are often minimal but growth potential can be significant, a higher ratio may be warranted when future prospects are strong.

Nuvalent is considered good value compared to its peer group, which trades at an average price-to-book of 21.1x. However, when viewed against the broader US Biotechs industry average of 2.5x, Nuvalent’s valuation appears much steeper, reflecting a significant premium that depends on strong future growth expectations.

See what the numbers say about this price — find out in our valuation breakdown.

Result: Price-to-Book of 8.3x (ABOUT RIGHT)

However, continued net losses and the lack of current revenue raise questions about how sustainable investor optimism will be if clinical results disappoint.

Find out about the key risks to this Nuvalent narrative.

If you have a different perspective or would like to dive into the numbers yourself, you can easily craft your own outlook on Nuvalent in just a few minutes. Do it your way

A great starting point for your Nuvalent research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.

Don’t let your next big opportunity slip past. Put your money to work in companies that match your strategy by using the Simply Wall Street Screener. Here are three distinct ways to get ahead of the market right now:

• Earn smarter by targeting portfolio income through these 16 dividend stocks with yields > 3% with yields above 3%, putting consistent returns at the heart of your investing approach.

• Unleash potential in fast-moving industries by finding these 24 AI penny stocks that are pioneering practical applications of artificial intelligence and reshaping the future.

• Position yourself early by tapping into these 26 quantum computing stocks bringing breakthroughs in computing power and disruptive solutions across tech sectors.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include NUVL.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Banco de Sabadell (BME:SAB) caught the market’s attention following its Q3 2025 results, reporting improved profitability and solid asset quality. The bank also updated its guidance and shareholder remuneration plans.

See our latest analysis for Banco de Sabadell.

After strong quarterly results and the bank’s upbeat guidance, Banco de Sabadell’s recent share price has cooled a little, dipping 2% over the past day and 7.6% in the past three months. That said, its year-to-date share price return of 71% and a remarkable 82% total shareholder return over the past year tell the story of a company still enjoying impressive long-term momentum, even as short-term sentiment reflects some caution around future growth levers.

If Sabadell’s streak has you on the lookout for fresh opportunities, now could be the perfect moment to discover fast growing stocks with high insider ownership.

With Sabadell’s robust returns and upgraded capital plans now in focus, the key question is whether the recent pullback leaves its shares undervalued or if the market has already accounted for its future growth prospects.

Banco de Sabadell’s widely followed narrative suggests the current share price sits below what the consensus sees as fair value, with a fair value estimate of €3.34 compared to the last close of €3.18. This modest gap puts the spotlight on the factors supporting further upside, outlined in the narrative below.

“Strong and accelerating loan growth, especially in Spanish mortgages, consumer lending (up 20%+ year-on-year), SME/corporate, public sector, and international portfolios, suggests robust underlying demand for banking services and positions the company for future revenue expansion and higher net interest income. Sustained increase in customer funds, particularly through off-balance sheet investment and savings products (up 6.7% year-on-year), demonstrates growing customer engagement and enables greater cross-selling of fee-based products. This supports long-term growth in recurring fee income and revenue diversification.”

Read the complete narrative.

Want to know how Sabadell’s long-term revenue mix and ambitious cost controls underpin this valuation? The blueprint combines rising loan demand and shifting profit margins with a profit multiple rarely seen in banks. Curious about what future projections analysts are banking on? Read the full narrative to uncover the numbers driving this fair value.

Result: Fair Value of €3.34 (UNDERVALUED)

Have a read of the narrative in full and understand what’s behind the forecasts.

However, continued reliance on Spain’s economy and sustained margin pressures could challenge Sabadell’s outlook, particularly if local conditions change unexpectedly.

Find out about the key risks to this Banco de Sabadell narrative.

If you see things differently, or want to dig into the numbers yourself, you can build your own view in just a few minutes. Do it your way.

A great starting point for your Banco de Sabadell research is our analysis highlighting 3 key rewards and 5 important warning signs that could impact your investment decision.

Why stop at one opportunity? Give yourself a real edge by leveraging powerful stock screens that uncover companies with potential most investors miss, often before they make headlines.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include SAB.MC.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

It takes time, money and fossil fuels to make the electronics that underpin modern life. From the mining of rare earths and metals to processing, manufacture and shipping, the engineering and logistical innovations that make it possible to buy a new phone every year produce incredible amounts of waste.

According to the latest Global E-Waste Monitor, the world is generating 62m tonnes of e-waste annually and is on track to reach 82m tonnes by 2030. Australia alone produces 580,000 tonnes yearly. Between planned obsolescence, advancing technology and genuine malfunctions, this figure is expected to rise.

An estimated 23m mobile phones sit idle in drawers around Australia, including about 13m that are unusable. The average Australian generates about 22kg of e-waste each year, almost three times the global average, according to a recent Productivity Commission inquiry.

“It’s the fastest growing waste stream but it’s also the most valuable,” says Anne Stonier, from the Australia New Zealand Recycling Platform (ANZRP). “There’s a lot of hard plastic as well, with electronics. By recycling it, you’re making sure it is being properly managed. You’re helping create a more circular economy.”

Where is best to dispose of old phones? How do you keep sensitive data safe? Here’s what to consider when recycling your old devices.

Look around for local recycling programs

Recycling e-waste is a little more complicated than simply throwing it into the yellow bin. The first step is to research options available near you. Local councils, for instance, have designated e-waste drop off points and recycling programs but the locations can vary. Disposing of e-waste in landfill is banned in Victoria, South Australia and Western Australia.

Likewise, several large retailers host recycling programs. Officeworks, for example, collects batteries, computer accessories, printer cartridges and mobile phones at its stores and runs drop-off days for most other electronic items. Bunnings stores maintain collection bins for batteries and larger electronic items such as TVs, screens, computers and printers. MobileMuster, a program run by the Australian telecommunications industry, collects mobile phones, speakers, smartwatches and tracking tags, modems, routers, landline phones and old TV streaming devices.

Many device manufacturers have set up stewardship programs to allow customers to trade in old phones and laptops in return for a discount or credit on their next purchase. If you’re thinking about an upgrade, it is worth checking what may be available to you.

There are also charities that accept donations of digital devices, such as DV Safe Phone and the Reconnect Project, which repairs used devices before providing them to people in need.

Disposing of devices that store personal information

Whether it’s a smartwatch tracking your regular jogging route, a tablet once used for business, or a personal phone full of photos, devices can hold intimate and sensitive information about our daily lives and activities.

Before disposing of electronic items, backup or transfer any files you want to keep to another device or storage device, such as an external hard drive, cloud service, USB or NAS system, and remove any physical markings or stickers that may associate the device with you.

What happens next depends on the device. For most smart devices, tablets and phones, it is enough to perform a factory reset. For computers, laptops, hard drives, USB sticks and other storage devices, reformatting the drive and performing a factory reset will also suffice. Fax machines, printers and scanners should also undergo a factory reset, as they can still hold copies of recently printed documents.

Finally, you should also take steps to unpair the old device with any remaining computers or devices.

If your device is so old that it won’t turn on and is not accessible when connected to a computer with a cable, there’s not much you can do. Make sure to remove any external or detachable memory storage, such as memory cards in old phones, before recycling.

What if my device holds very sensitive material?

Physical destruction, such as drilling through a hard drive, is unlikely to work and defeats the purpose of recycling in the first place. It can also be dangerous, especially if you are attempting to destroy a device with a battery that cannot be removed and cause a rupture that leads to fire or a health hazard.

If your device contains very sensitive information that you want to be sure is destroyed, consider reformatting the device, using data sanitisation software and encrypting the hard drive. Secure data destruction services are also available. The nature of these services vary, however, as does price. Some companies may offer a free data destruction service on donated hard drives so they can cannibalise them for parts to perform repairs for their clients. Other services are geared more towards large corporates.

Stonier says some specialist recyclers also offer data destruction services. “If there’s any concern about it getting into someone else’s hands, it’s better to just wipe it,” she says. “You just don’t know otherwise. It’s better to be safe than sorry.”

What happens if I don’t do any of this?

Some threats are more significant than others. A hard drive that contains nothing but family photos is lower risk than one that holds detailed financial information. For most people, it is unlikely they will ever be specifically targeted unless they have a reason or are already vulnerable in some way.

Much criminal activity tends to be opportunistic, meaning that, for most people, even taking a few basic steps can help stop a headache or a fright later.

What are the early trends we should look for to identify a stock that could multiply in value over the long term? Amongst other things, we’ll want to see two things; firstly, a growing return on capital employed (ROCE) and secondly, an expansion in the company’s amount of capital employed. Ultimately, this demonstrates that it’s a business that is reinvesting profits at increasing rates of return. Speaking of which, we noticed some great changes in Ambertech’s (ASX:AMO) returns on capital, so let’s have a look.

This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

For those who don’t know, ROCE is a measure of a company’s yearly pre-tax profit (its return), relative to the capital employed in the business. Analysts use this formula to calculate it for Ambertech:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets – Current Liabilities)

0.094 = AU$2.5m ÷ (AU$53m – AU$27m) (Based on the trailing twelve months to June 2025).

Therefore, Ambertech has an ROCE of 9.4%. Even though it’s in line with the industry average of 9.4%, it’s still a low return by itself.

View our latest analysis for Ambertech

While the past is not representative of the future, it can be helpful to know how a company has performed historically, which is why we have this chart above. If you want to delve into the historical earnings , check out these free graphs detailing revenue and cash flow performance of Ambertech.

We’re glad to see that ROCE is heading in the right direction, even if it is still low at the moment. The numbers show that in the last five years, the returns generated on capital employed have grown considerably to 9.4%. Basically the business is earning more per dollar of capital invested and in addition to that, 25% more capital is being employed now too. This can indicate that there’s plenty of opportunities to invest capital internally and at ever higher rates, a combination that’s common among multi-baggers.

On a separate but related note, it’s important to know that Ambertech has a current liabilities to total assets ratio of 50%, which we’d consider pretty high. This can bring about some risks because the company is basically operating with a rather large reliance on its suppliers or other sorts of short-term creditors. While it’s not necessarily a bad thing, it can be beneficial if this ratio is lower.

A company that is growing its returns on capital and can consistently reinvest in itself is a highly sought after trait, and that’s what Ambertech has. Considering the stock has delivered 18% to its stockholders over the last five years, it may be fair to think that investors aren’t fully aware of the promising trends yet. Given that, we’d look further into this stock in case it has more traits that could make it multiply in the long term.

On a final note, we found 4 warning signs for Ambertech (1 makes us a bit uncomfortable) you should be aware of.

While Ambertech isn’t earning the highest return, check out this free list of companies that are earning high returns on equity with solid balance sheets.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.